/Investor DB

Amed Ventures — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

Neurolutionsneurolutions.cominFeb 2025

Neurolutions develops IpsiHand, an FDA-cleared non-invasive brain-computer interface therapy for upper-extremity motor rehabilitation in chronic stroke survivors.

BiotechDeep TechDigital HealthHealthtechMedical DevicesVan Nuys, US

Eric Leuthardt(Founder (lab origin at Washington University in St. Louis))inLeo Petrossian(Chief Executive Officer & Director)inNabeel Ahmed(Chief Financial Officer)Kirsten Carroll(Chief Marketing Officer & General Manager, Service)Andy Schultz(Chief Commercial Officer)Javad Seyedzadeh(Chief Operations Officer)

Co-investorsBioGenerator VenturesExcelestar VenturesAlly Bridge Group

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.